; and (iii) based in the United States. (B) Inclusions The proposed regulations under subparagraph (A) shall— (i) support good labor conditions, worker protections, and employee rights to organize and collectively bargain; and (ii) ensure the global trade competitiveness of the United States, including by considering the comparative carbon intensity of domestic and internationally manufactured pharmaceuticals and medical products. (3) Grant program Based on the findings of the assessment conducted under paragraph (1)(A), the Council shall develop recommendations for a grant program to be carried out by the Secretary under which the Secretary would make grants for medical manufacturing to support the development and establishment of sustainable and zero-emission medical supply chains based in the United States. (d) Regulations (1) In general Not later than 1 year after the date of enactment of this Act, the Secretary shall develop and promulgate regulations to support a medical supply chain that is— (A) sustainable; (B) free of greenhouse gas emissions